Bioclonetics Immunotherapeutics - 0001665160-19-000597

Company Offering
Bioclonetics Immunotherapeutics
SEC Accession #

0001665160-19-000597

Filing Date

Investment Security Details

Submission
C-AR

Investing Platform Detail

Offering Company Details

Executive Signatory
Charles S. Cotropia
Title
CEO, Principal Executive Officer and Director, Principal Financial Officer and Principal Accounting Officer
Website
www.bioclonetics.com
Employee Count at Offering
4
SEC CIK
1701251
FILE NUMBER
020-23301

Comments